{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:31:21Z","timestamp":1792647081279,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jacc.2026.01.055","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:05:45Z","timestamp":1773237945000},"page":"2948-2959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Emulated Effects of Glucagon-Like Peptide 1 Receptor Agonist Therapy in the General Population"],"prefix":"10.1016","volume":"87","author":[{"given":"Benedikt","family":"Schrage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian Karl","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisouda","family":"Hoshiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"de Lemos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Grossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ittermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiess","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus N.","family":"Lyngbakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6452-0369","authenticated-orcid":false,"given":"Torbj\u00f8rn","family":"Omland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demosthenes B.","family":"Panagiotakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"Ris\u00e9rus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sch\u00f6ttker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"S\u00f6derberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Thorand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Goya","family":"Wannamethee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco M.","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Blankenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Magnussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2026.01.055_bib1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa2206916","article-title":"Global effect of modifiable risk factors on cardiovascular disease and mortality","volume":"389","author":"Magnussen","year":"2023","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jacc.2026.01.055_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa2415879","article-title":"Global effect of cardiovascular risk factors on lifetime estimates","volume":"393","author":"Magnussen","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.01.055_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.01.055_bib4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacc.2026.01.055_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/ije\/dyh327","article-title":"MORGAM (an international pooling of cardiovascular cohorts)","volume":"34","author":"Evans","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacc.2026.01.055_bib6","series-title":"Individual Participant Data Meta-Analysis: a Handbook for Healthcare Research","first-page":"447","article-title":"IPD meta-analysis for clinical prediction model research","author":"Riley","year":"2021"},{"issue":"29","key":"10.1016\/j.jacc.2026.01.055_bib7","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1002\/sim.8362","article-title":"An extended mixed-effects framework for meta-analysis","volume":"38","author":"Sera","year":"2019","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.jacc.2026.01.055_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2307\/2531910","article-title":"Sample sizes based on the log-rank statistic in complex clinical trials","volume":"44","author":"Lakatos","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jacc.2026.01.055_bib9","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.jacc.2026.01.055_bib10","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2026.01.055_bib11","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(17)30721-3","article-title":"Lessons from the controversy over statins","volume":"389","author":"Godlee","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2026.01.055_bib12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1001\/jama.2022.12138","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"328","author":"Chou","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2026.01.055_bib13","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1161\/CIRCULATIONAHA.108.768986","article-title":"Medication adherence: its importance in cardiovascular outcomes","volume":"119","author":"Ho","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2026.01.055_bib14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCRESAHA.118.313220","article-title":"Adherence in hypertension","volume":"124","author":"Burnier","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2026.01.055_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6123","article-title":"Should people at low risk of cardiovascular disease take a statin?","volume":"347","author":"Abramson","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2026.01.055_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/02813432.2025.2477141","article-title":"Patients\u2019 experiences with GLP1-RAs\u2014a systematic review","volume":"43","author":"Ibsen","year":"2025","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.jacc.2026.01.055_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109035","article-title":"Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting","volume":"180","author":"Rea","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jacc.2026.01.055_bib18","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/ije\/dyp192","article-title":"Intervening on risk factors for coronary heart disease: an application of the parametric g-formula","volume":"38","author":"Taubman","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jacc.2026.01.055_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2023.07.008","article-title":"The role of adherence in patients with chronic diseases","volume":"119","author":"Burnier","year":"2024","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jacc.2026.01.055_bib20","doi-asserted-by":"crossref","first-page":"7210","DOI":"10.1111\/dom.70121","article-title":"Cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists is proportional to HbA1c lowering in type 2 diabetes: an updated meta-regression analysis incorporating FLOW and SOUL trials","volume":"12","author":"Hasebe","year":"2025","journal-title":"Diabetes Obes Metab"}],"container-title":["JACC"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109726002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:43:18Z","timestamp":1780411398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109726002342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0735109726002342"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2026.01.055","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emulated Effects of Glucagon-Like Peptide 1 Receptor Agonist Therapy in the General Population","name":"articletitle","label":"Article Title"},{"value":"JACC","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2026.01.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}